Results 11 to 20 of about 156,165 (266)

Kaplan–Meier Estimator under Association

open access: yesJournal of Multivariate Analysis, 1998
This work studies the Kaplan-Meier estimator and the estimation of the hazard function in a model with censored failure times. The true survival times \(T_1,\dots T_n\), with common marginal \(F\), are not assumed mutually independent. They satisfy two different notions of weak dependence: a) They are positively associated, i.e.
Cai, Zongwu, Roussas, George G.
openaire   +2 more sources

A Generalized Kaplan-Meier Estimator

open access: yesThe Annals of Statistics, 1984
A class of nonparametric maximum likelihood estimators of the survival function based on incomplete or right-censored data is derived in the general situation that the time to death and the time to loss (censoring) are not necessarily independent. This is the competing risks problem with two causes of failure.
Robertson, James B., Uppuluri, V. R. R.
openaire   +2 more sources

Influencing factors of pregnancy loss and survival probability of clinical pregnancies conceived through assisted reproductive technology

open access: yesReproductive Biology and Endocrinology, 2018
Background Pregnancies following assisted reproductive technology (ART) may have elevated potential risk of pregnancy loss (PL) when compared to natural conception.
Lingmin Hu   +15 more
doaj   +1 more source

Association between Birth Region and Time to Tuberculosis Diagnosis among Non–US-Born Persons in the United States

open access: yesEmerging Infectious Diseases, 2021
Approximately 90% of tuberculosis (TB) cases among non–US-born persons in the United States are attributable to progression of latent TB infection to TB disease.
Amish Talwar, Rongxia Li, Adam J. Langer
doaj   +1 more source

Serum glucose, cholesterol and blood pressure levels in Japanese type 1 and 2 diabetic patients: BioBank Japan

open access: yesJournal of Epidemiology, 2017
Background: Evidence of characteristics of Japanese patients with diabetes from a large-scale population is necessary. Few studies have compared glycaemic controls, complications and comorbidities between type 1 and 2 diabetic patients.
Hiroshi Yokomichi
doaj   +1 more source

Estimating Hazard Function and Survival Analysis of Tuberculosis Patients in Erbil city

open access: yesTikrit Journal of Administrative and Economic Sciences, 2021
The study aimed to estimate the effects of prognostic factors on tuberculosis (TB) survival. Two models have been studied (Logistic model and Cox regression models) in survival analysis.
Kurdistan Ibrahim Mawlood   +1 more
doaj   +1 more source

Statin use and all-cause and cancer mortality: BioBank Japan cohort

open access: yesJournal of Epidemiology, 2017
Background: Statins are the first-line agents used to treat patients with high serum low-density lipoprotein cholesterol levels, thus reducing the risk of death from arterial sclerotic cardiovascular disease; however, little is known about the effects of
Hiroshi Yokomichi
doaj   +1 more source

Private and Collaborative Kaplan-Meier Estimators

open access: yesProceedings of the 23rd Workshop on Privacy in the Electronic Society, 2023
Kaplan-Meier estimators are essential tools in survival analysis, capturing the survival behavior of a cohort. Their accuracy improves with large, diverse datasets, encouraging data holders to collaborate for more precise estimations. However, these datasets often contain sensitive individual information, necessitating stringent data protection ...
Shadi Rahimian   +3 more
openaire   +2 more sources

Survival of silver diamine fluoride among patients treated in community dental clinics: a naturalistic study

open access: yesBMC Oral Health, 2021
Background Silver diamine fluoride (SDF) is a minimally-invasive preventive service used in the U.S. to avert and arrest caries since 2014. No studies document survival outcomes based in real world delivery.
Sarah E. Raskin   +5 more
doaj   +1 more source

Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma

open access: yesFrontiers in Oncology, 2023
BackgroundPembrolizumab, a PD-1 immune checkpoint inhibitor, is approved as first-line (1L) treatment for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) as monotherapy or in combination with platinum and 5-fluorouracil ...
Christopher M. Black   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy